サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1595053

オプトジェネティクス・アクチュエーターとセンサーの世界市場

Optogenetics Actuators and Sensors

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
オプトジェネティクス・アクチュエーターとセンサーの世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オプトジェネティクス・アクチュエーターとセンサーの世界市場は2030年までに6億1,890万米ドルに達する見込み

2023年に5億4,550万米ドルと推定されるオプトジェネティクス・アクチュエーターとセンサーの世界市場は、分析期間2023-2030年にCAGR 1.8%で成長し、2030年には6億1,890万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアクチュエータは、CAGR 1.4％を記録し、分析期間終了時には4億540万米ドルに達すると予測されています。センサセグメントの成長率は、分析期間中CAGR 2.6％と推定されます。

米国市場は1億4,580万米ドルと推定、中国はCAGR1.6％で成長予測

米国のオプトジェネティクス・アクチュエーターとセンサー市場は、2023年に1億4,580万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9,820万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは1.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9％と1.2％と予測されています。欧州では、ドイツがCAGR 1.7%で成長すると予測されています。

世界のオプトジェネティクス・アクチュエーターとセンサー市場- 主要動向と促進要因のまとめ

オプトジェネティクス・アクチュエーターとセンサーは神経科学調査にどのような革命をもたらしたか？

オプトジェネティクス・アクチュエーターとセンサーは神経科学研究に大きな変革をもたらし、科学者たちはかつてない精度で神経細胞の活動を制御・監視できるようになりました。遺伝学的手法と光学的手法を組み合わせることで、光遺伝学は、研究者が光感受性タンパク質を用いて生体内の特定のニューロンを活性化または抑制することを可能にし、その結果、脳機能、神経回路、および行動に関する洞察を提供します。従来の電気刺激法とは異なり、オプトジェネティクスでは細胞タイプに特異性があるため、周囲の細胞に影響を与えることなく、神経経路を標的として操作することができます。このブレークスルーにより、認知、感情、疾患の根底にある神経プロセスの理解が深まり、うつ病、パーキンソン病、統合失調症などの複雑な神経疾患の研究において、オプトジェネティクスは非常に貴重なツールとなっています。チャネルロドプシンやハロロドプシンなどの光遺伝学的アクチュエータは、正確なタイミングで神経信号を活性化または抑制することができます。

基礎的な神経科学にとどまらず、オプトジェネティクスは、感覚知覚、記憶、意思決定などの分野の研究を発展させてきました。光遺伝学的アクチュエータを使って特定のニューロンを刺激したり抑制したりすることで、研究者は、異なる脳領域が感覚処理にどのように寄与しているか、あるいは記憶がどのように形成され、取り出されるかを調査することができます。この技術により、特定の神経回路を活性化することで、動物モデルで特定の行動を再現することも可能になり、複雑な行動が脳内でどのように組織化されるかについて、ユニークな視点を提供することができます。例えば、学習と記憶の研究において、オプトジェネティクスは情報の符号化や検索に関与するニューロンを標的とすることができ、研究者がこれらのプロセスを担う正確な神経回路を特定するのに役立ちます。神経活動をこのレベルで制御することで、画期的な発見が生まれ、光遺伝学は脳機能の基本的なメカニズムを理解するために不可欠な技術として位置づけられています。

遺伝的にコード化されたカルシウムインジケータ（GECI）などの光遺伝学的センサーの開発により、研究者は神経活動をリアルタイムで観察できるようになり、光遺伝学の応用範囲がさらに広がった。これらのセンサーは神経活動に応答して蛍光を発するため、脳機能をダイナミックに視覚化することができます。この機能は、治療や行動介入に応じて神経活動が経時的にどのように変化するかをモニターする必要がある縦断的研究で特に有用です。アクチュエーターとセンサーを組み合わせることで、オプトジェネティクスは神経回路の操作とモニタリングの両方を可能にする二重のアプローチを提供し、総合的な神経科学研究のための強力なプラットフォームとなります。高い空間的・時間的解像度で神経細胞反応を刺激・記録する能力は、神経結合、可塑性、機能障害に関する我々の理解を一変させ、神経学や精神医学における新たな治療戦略への道を開いています。

オプトジェネティクス・ツールが遺伝子治療と精密医療の進歩に極めて重要なのはなぜか？

アクチュエータとセンサーの両方を含むオプトジェネティクス・ツールは、遺伝子治療と精密医療を前進させる上でますます極めて重要なものとなっており、遺伝子疾患や神経疾患を研究し、潜在的に治療するための新たな方法を提供しています。遺伝子治療研究は光遺伝学から大きな恩恵を受けています。研究者は光遺伝学アクチュエータを使用して、特定の細胞タイプにおける遺伝子発現を選択的に活性化または抑制することができ、遺伝子機能を探索する精密なアプローチを提供できるからです。このような標的制御は、分子レベルで遺伝性疾患を理解する上で非常に貴重であり、研究者は、治療効果を得るために改変できる特定の遺伝経路を特定することができます。ハンチントン病やアルツハイマー病のような神経変性疾患では、光遺伝学的アクチュエータは、特定の遺伝子が疾患の進行にどのように関与しているかを科学者が調査するのに役立ち、新たな治療戦略につながる知見を提供することができます。さらに、オプトジェネティクスを使って生きたモデルで遺伝子発現を制御することで、研究者は遺伝子改変の効果をリアルタイムで評価することができ、これは効果的な標的遺伝子治療の開発に不可欠です。

精密医療の領域では、光遺伝学的センサーによって、研究者は細胞の生化学的・生理学的状態を極めて正確にモニターすることができます。例えば、カルシウムや神経伝達物質のレベルを検出するように設計されたセンサーは、健康な細胞と病気の細胞との間で細胞反応がどのように異なるかを明らかにし、病気の進行における個人差についての洞察を提供することができます。この情報は、患者一人一人の遺伝的・分子的プロファイルに合わせた治療を行う精密医療において極めて重要です。オプトジェネティクスは、細胞反応をきめ細かく調べることを可能にし、特定の治療に対する患者の反応を予測するバイオマーカーの同定を容易にします。これらの洞察を活用することで、臨床医は個別化された治療計画を立てることができ、てんかんやある種の精神疾患など、従来治療が困難であった疾患の予後を改善できる可能性があります。

さらに、光遺伝学は精密医療における治療応用の可能性を提供します。光遺伝学的アクチュエータは、光刺激に反応するように設計することができ、標的組織の細胞機能を正確に制御することができるからです。例えば、研究者たちは、光感受性タンパク質を網膜細胞に導入することで、網膜変性患者の視力を回復させる光遺伝学的アプローチを模索しています。この方法は、視覚機能を部分的に回復させる可能性があり、これまで治療不可能と考えられていた状態に対処する有望な手段となります。将来的には、オプトジェネティクスは、細胞活動の精密な制御が必要とされる心筋梗塞や筋疾患など、その他の疾患に対する標的療法の開発にも利用される可能性があります。オプトジェネティクス技術が進化を続けるにつれ、遺伝子治療や精密医療への応用が拡大し、次世代治療戦略の開発に大きな期待が寄せられています。

オプトジェネティクス・アクチュエーターとセンサーはメンタルヘルスと神経調節療法をどのようにサポートするのか？

オプトジェネティクスは、精神疾患や神経疾患に関連する神経回路を研究し、潜在的に調節するための強力なツールを提供することで、メンタルヘルスや神経調節療法において変革的な役割を果たしています。この分野におけるオプトジェネティクスの重要な応用例の1つは、うつ病、不安、依存症などの精神疾患の根底にある神経メカニズムの調査です。光遺伝学的アクチュエータを使用して特定の神経経路を活性化または抑制することにより、研究者はこれらの障害の原因となる回路を特定することができ、これは標的療法の開発に不可欠です。例えば、うつ病の研究では、気分の調節に関与する脳領域である前頭前野のニューロンを刺激するために光遺伝学が用いられてきました。この部位の活動を制御することで、神経シグナル伝達の変化が抑うつ行動にどのように影響するかを調査することができ、経頭蓋磁気刺激や脳深部刺激など、より効果的な神経調節療法につながる知見を得ることができます。

オプトジェネティクスはまた、精神疾患や神経疾患の治療のために神経活動を変化させることを目的としたニューロモジュレーション療法の開発もサポートしています。電気刺激や磁気刺激などのニューロモジュレーション技術は、てんかんや慢性疼痛などの治療にすでに用いられているが、オプトジェネティクスはより正確な代替手段を提供します。光で作動するアクチュエータで特定のニューロンをターゲットにすることで、光遺伝学は脳回路の選択的な変調を可能にします。例えば依存症研究では、オプトジェネティクスによって動物モデルの報酬経路を操作することが可能になり、これらの回路がどのように依存行動に関与しているかについての知見が得られました。これらの知見は、特定の神経回路を標的として欲求を抑えたり、再発を予防したりする新たな治療法への道を開く可能性があり、依存症治療に新たなアプローチを提供するものです。

メンタルヘルス研究における光遺伝学的センサーの使用は、精神科治療薬が細胞レベルで脳にどのような影響を与えるかについての理解も進めています。薬物投与後の神経伝達物質レベルや神経細胞活動の変化を観察することで、研究者は抗うつ薬や抗精神病薬のような薬物が特定の神経回路とどのように相互作用するかを調査することができます。この情報は、既存の治療法を改善したり、精神疾患に関与する特定の経路を標的とする新薬を開発したりする上で貴重です。さらに、オプトジェネティクスは、従来の治療法では効果が限定的であった治療抵抗性疾患に関する知見を提供することができます。治療抵抗性に関連する正確な回路を同定することにより、光遺伝学は、課題となっている精神疾患患者の転帰を改善するための標的化神経調節などの代替アプローチの開発に役立つ可能性があります。メンタルヘルスの研究が脳の複雑な回路を探求し続ける中、様々な障害に的を絞った効果的な治療法を提供する治療法を開発する上で、オプトジェネティクスは非常に有用であることが証明されています。

オプトジェネティクス・アクチュエーターとセンサー市場の成長の原動力は？

オプトジェネティクス・アクチュエーターとセンサー市場の成長は、神経科学研究の進歩、メンタルヘルス治療への注目の高まり、遺伝子治療や精密医療の応用拡大など、いくつかの重要な要因によってもたらされています。神経科学研究は、神経細胞活動の精密な制御を可能にする光遺伝学的ツールの開発に後押しされ、最近の動向は著しいです。光遺伝学によって、研究者は神経回路をかつてないほど詳細に調査することができ、脳機能、認知、行動に関する貴重な発見につながります。学術研究や製薬研究において光遺伝学技術の採用が増加しているため、特異性、信頼性、使いやすさを提供するアクチュエータやセンサの需要が高まっており、神経科学が回路レベルの洞察にますます焦点を当てるようになるにつれて、この市場の成長を支えています。

精神疾患や神経疾患の根底にある神経メカニズムの解明を研究者が求めているため、メンタルヘルス治療への注目の高まりもオプトジェネティクス市場の大きな促進要因となっています。うつ病、不安症、中毒、統合失調症などの症状は複雑で多因子であり、これらの症状に関与する特定の神経経路を解剖できるツールが必要です。光遺伝学的アクチュエータとセンサーは、これらの経路を研究するための的を絞ったアプローチを提供し、潜在的な治療標的を特定し、効果的な治療法を開発するのに役立ちます。メンタルヘルス研究が拡大し、新しい治療戦略が開発されるにつれて、神経精神医学研究におけるオプトジェネティクスツールの需要が高まり、市場成長にさらに拍車がかかると見られています。

さらに、遺伝子治療や精密医療におけるオプトジェネティクスの応用拡大が市場需要に大きく寄与しています。光遺伝学ツールは、遺伝子発現と細胞活性の正確な制御を可能にし、CRISPRのような遺伝子編集技術の研究をサポートし、標的療法の開発を進めるのに役立ちます。光遺伝学が網膜変性における視力回復や精神的健康のための標的神経調節などの治療ソリューションを提供する可能性は、精密医療におけるその役割を強調しています。遺伝子治療と個別化医療が牽引力を持ち続ける中、オプトジェネティクス・アクチュエーターとセンサーの需要は、個々の遺伝的・分子的プロファイルに対応したオーダーメイド治療の創出における有用性によって拡大すると予想されます。これらの要因が相まって、科学・医学研究におけるオプトジェネティクスの範囲拡大と重要性が強調され、オプトジェネティクス・アクチュエーターとセンサー市場の持続的成長を後押ししています。

セグメント

製品タイプ（アクチュエータ、センサ）;疾患タイプ（網膜障害、パーキンソン病、自閉症、不安・うつ病、統合失調症、その他の疾患タイプ）

調査対象企業の例（全42件）

  • Addgene
  • AGTC
  • and Circuit Therapeutics, Inc.
  • Bruker
  • Coherent, Inc.
  • Danaher
  • Gensight Biologics
  • lliot Scientific Ltd.
  • Merck KGaA
  • Noldus Information Technology
  • Prizmatix
  • Scientifica（Judges Scientific Plc Company）
  • Shanghai Laser & Optics Century Co., Ltd.（SLOC）
  • The Jackson Laboratory
  • Thorlabs, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22430

Global Optogenetics Actuators and Sensors Market to Reach US$618.9 Million by 2030

The global market for Optogenetics Actuators and Sensors estimated at US$545.5 Million in the year 2023, is expected to reach US$618.9 Million by 2030, growing at a CAGR of 1.8% over the analysis period 2023-2030. Actuators, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$405.4 Million by the end of the analysis period. Growth in the Sensors segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$145.8 Million While China is Forecast to Grow at 1.6% CAGR

The Optogenetics Actuators and Sensors market in the U.S. is estimated at US$145.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$98.2 Million by the year 2030 trailing a CAGR of 1.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 1.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Optogenetics Actuators and Sensors Market - Key Trends & Drivers Summarized

How Have Optogenetics Actuators and Sensors Revolutionized Neuroscience Research?

Optogenetics actuators and sensors have profoundly transformed neuroscience research, allowing scientists to control and monitor neuronal activity with unprecedented precision. By combining genetic and optical methods, optogenetics enables researchers to activate or inhibit specific neurons in living organisms using light-sensitive proteins, thus providing insights into brain function, neural circuits, and behavior. Unlike traditional electrical stimulation methods, optogenetics offers cell-type specificity, allowing targeted manipulation of neural pathways without affecting surrounding cells. This breakthrough has facilitated a deeper understanding of neural processes underlying cognition, emotion, and disease, making optogenetics an invaluable tool in studying complex neurological conditions like depression, Parkinson’s disease, and schizophrenia. Optogenetic actuators, such as channelrhodopsins and halorhodopsins, allow for the activation or suppression of neural signals with precise timing, which is essential for dissecting the causal relationships between neural activity and behavior.

Beyond basic neuroscience, optogenetics has advanced research in areas such as sensory perception, memory, and decision-making. By using optogenetic actuators to stimulate or inhibit specific neurons, researchers can study how different brain regions contribute to sensory processing or how memories are formed and retrieved. This technique has even enabled scientists to recreate specific behaviors in animal models by activating certain neural circuits, providing a unique perspective on how complex behaviors are orchestrated in the brain. For example, in studies of learning and memory, optogenetics can target neurons involved in encoding or retrieving information, helping researchers identify the precise neural circuits responsible for these processes. This level of control over neural activity has given rise to groundbreaking discoveries, positioning optogenetics as an essential technique for understanding the fundamental mechanisms of brain function.

The development of optogenetic sensors, such as genetically encoded calcium indicators (GECIs), has further expanded the applications of optogenetics by allowing researchers to observe real-time neural activity. These sensors fluoresce in response to neural activity, providing a dynamic visual representation of brain function as it unfolds. This capability is especially useful in longitudinal studies where researchers need to monitor how neural activity changes over time in response to treatments or behavioral interventions. By combining actuators and sensors, optogenetics offers a dual approach that enables both manipulation and monitoring of neural circuits, making it a powerful platform for comprehensive neuroscience research. The ability to both stimulate and record neuronal responses with high spatial and temporal resolution has transformed our understanding of neural connectivity, plasticity, and dysfunction, paving the way for novel therapeutic strategies in neurology and psychiatry.

Why Are Optogenetics Tools Pivotal in Advancing Gene Therapy and Precision Medicine?

Optogenetics tools, including both actuators and sensors, are increasingly pivotal in advancing gene therapy and precision medicine, providing new methods to study and potentially treat genetic and neurological disorders. Gene therapy research benefits significantly from optogenetics, as researchers can use optogenetic actuators to selectively activate or suppress gene expression in specific cell types, offering a precise approach to exploring gene function. This targeted control is invaluable for understanding genetic diseases at the molecular level, enabling researchers to identify specific genetic pathways that could be modified for therapeutic benefit. In neurodegenerative diseases like Huntington’s or Alzheimer’s, optogenetic actuators can help scientists investigate how specific genes contribute to disease progression, providing insights that could lead to new treatment strategies. Furthermore, by using optogenetics to control gene expression in live models, researchers can assess the effects of gene modifications in real-time, which is essential for developing effective, targeted gene therapies.

In the realm of precision medicine, optogenetic sensors allow researchers to monitor the biochemical and physiological states of cells with extraordinary accuracy. For example, sensors designed to detect calcium or neurotransmitter levels can reveal how cellular responses differ between healthy and diseased cells, offering insights into individual variations in disease progression. This information is critical in precision medicine, where treatments are tailored to the unique genetic and molecular profile of each patient. Optogenetics enables the exploration of cellular responses on a granular level, facilitating the identification of biomarkers that could predict patient responses to specific therapies. By leveraging these insights, clinicians can develop personalized treatment plans, potentially improving outcomes for conditions that have traditionally been difficult to treat, such as epilepsy and certain psychiatric disorders.

Additionally, optogenetics offers potential therapeutic applications in precision medicine, as optogenetic actuators can be engineered to respond to light stimulation, enabling precise control over cellular functions in targeted tissues. For example, researchers are exploring optogenetic approaches for restoring vision in patients with retinal degeneration by introducing light-sensitive proteins into retinal cells. This method has the potential to partially restore visual function, offering a promising avenue for addressing conditions previously considered untreatable. In the future, optogenetics could be used to develop targeted therapies for other diseases, including cardiac arrhythmias and muscle disorders, where precise control over cellular activity is required. As optogenetics technology continues to evolve, its applications in gene therapy and precision medicine are expanding, holding significant promise for the development of next-generation therapeutic strategies.

How Do Optogenetics Actuators and Sensors Support Mental Health and Neuromodulation Therapies?

Optogenetics is playing a transformative role in mental health and neuromodulation therapies by providing a powerful tool for studying and potentially modulating neural circuits associated with psychiatric and neurological disorders. One of the key applications of optogenetics in this field is in researching the neural mechanisms underlying mental health conditions like depression, anxiety, and addiction. By using optogenetic actuators to activate or inhibit specific neural pathways, researchers can identify the circuits that contribute to these disorders, which is essential for developing targeted therapies. For instance, in depression research, optogenetics has been used to stimulate neurons in the prefrontal cortex, a brain region implicated in mood regulation. By controlling activity in this area, researchers can investigate how changes in neural signaling influence depressive behaviors, providing insights that could lead to more effective neuromodulation therapies, such as transcranial magnetic stimulation or deep brain stimulation.

Optogenetics also supports the development of neuromodulation therapies that aim to alter neural activity to treat mental health and neurological conditions. Neuromodulation techniques, including electrical and magnetic stimulation, are already used to treat conditions like epilepsy and chronic pain, but optogenetics offers a more precise alternative. By targeting specific neurons with light-activated actuators, optogenetics allows for selective modulation of brain circuits, which could reduce side effects associated with less targeted stimulation techniques. In addiction research, for example, optogenetics has enabled researchers to manipulate reward pathways in animal models, providing insights into how these circuits contribute to addictive behaviors. These findings could pave the way for new therapies that target specific neural circuits to reduce cravings or prevent relapse, offering a novel approach to addiction treatment.

The use of optogenetic sensors in mental health research is also advancing our understanding of how psychiatric medications affect the brain on a cellular level. By observing changes in neurotransmitter levels or neuronal activity following drug administration, researchers can study how medications like antidepressants or antipsychotics interact with specific neural circuits. This information is valuable for improving existing treatments and developing new drugs that target specific pathways implicated in mental health conditions. Furthermore, optogenetics can provide insights into treatment-resistant conditions, where traditional therapies have limited efficacy. By identifying the precise circuits associated with treatment resistance, optogenetics could inform the development of alternative approaches, such as targeted neuromodulation, to improve outcomes for patients with challenging psychiatric conditions. As mental health research continues to explore the brain’s intricate circuitry, optogenetics actuators and sensors are proving invaluable in developing therapies that offer targeted, effective treatment options for a range of disorders.

What Is Fueling the Growth in the Optogenetics Actuators and Sensors Market?

The growth in the optogenetics actuators and sensors market is driven by several key factors, including advances in neuroscience research, increased focus on mental health therapies, and the expanding applications of gene therapy and precision medicine. Neuroscience research has seen significant growth over recent years, fueled by the development of optogenetic tools that enable precise control over neuronal activity. Optogenetics allows researchers to study neural circuits in unprecedented detail, leading to valuable discoveries about brain function, cognition, and behavior. The increasing adoption of optogenetic technologies in academic and pharmaceutical research is driving demand for actuators and sensors that offer specificity, reliability, and ease of use, supporting the growth of this market as neuroscience becomes increasingly focused on circuit-level insights.

The rising focus on mental health therapies is another major driver for the optogenetics market, as researchers seek to understand the neural mechanisms underlying psychiatric and neurological disorders. Conditions such as depression, anxiety, addiction, and schizophrenia are complex and multifactorial, requiring tools that can dissect specific neural pathways involved in these conditions. Optogenetic actuators and sensors offer a targeted approach for studying these pathways, helping to identify potential therapeutic targets and develop effective treatments. As mental health research expands and new treatment strategies are developed, the demand for optogenetics tools in neuropsychiatric research is expected to rise, further fueling market growth.

Furthermore, the expanding applications of optogenetics in gene therapy and precision medicine are contributing significantly to market demand. Optogenetic tools enable precise control over gene expression and cellular activity, supporting research in gene-editing techniques like CRISPR and helping to advance the development of targeted therapies. The potential for optogenetics to offer therapeutic solutions, such as vision restoration in retinal degeneration and targeted neuromodulation for mental health, underscores its role in precision medicine. As gene therapy and personalized medicine continue to gain traction, the demand for optogenetics actuators and sensors is expected to grow, driven by their utility in creating customized treatments that address individual genetic and molecular profiles. Together, these factors underscore the expanding scope and importance of optogenetics in scientific and medical research, driving sustained growth in the optogenetics actuators and sensors market.

SCOPE OF STUDY:

The report analyzes the Optogenetics Actuators and Sensors market in terms of US$ Thousand by the following Disease Type; Product, and Geographic Regions/Countries:

Segments:

Product (Actuators, Sensors); Disease Type (Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia, Other Disease Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Addgene
  • AGTC
  • and Circuit Therapeutics, Inc.
  • Bruker
  • Coherent, Inc.
  • Danaher
  • Gensight Biologics
  • lliot Scientific Ltd.
  • Merck KGaA
  • Noldus Information Technology
  • Prizmatix
  • Scientifica (Judges Scientific Plc Company)
  • Shanghai Laser & Optics Century Co., Ltd. (SLOC)
  • The Jackson Laboratory
  • Thorlabs, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Optogenetics Actuators and Sensors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Research in Neuroscience Drives Adoption of Optogenetics
    • Increasing Applications in Neurological Disorder Treatments Propel Market Growth
    • Advancements in Light-Sensitive Proteins Expand Market Potential for Optogenetics
    • Rising Use of Optogenetics in Brain Mapping Spurs Demand
    • Adoption in Psychiatric Disorder Studies Sets the Stage for Market Expansion
    • Increasing R&D in Biopharmaceuticals Drives Demand for Optogenetics Tools
    • Use of Optogenetics in Cardiovascular Research Expands Addressable Market
    • Use of Optogenetics in Pain Management Strengthens Market Potential
    • Increasing Research Funding for Neuroscience Studies Sets the Stage for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Optogenetics Actuators and Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Optogenetics Actuators and Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Actuators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Actuators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Actuators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Retinal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Retinal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Retinal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Autism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Autism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Autism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Anxiety & Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Anxiety & Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Anxiety & Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Optogenetics Actuators and Sensors Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • CHINA
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Optogenetics Actuators and Sensors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Optogenetics Actuators and Sensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Optogenetics Actuators and Sensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Product - Actuators and Sensors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Optogenetics Actuators and Sensors by Product - Actuators and Sensors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Optogenetics Actuators and Sensors by Product - Percentage Breakdown of Value Sales for Actuators and Sensors for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Optogenetics Actuators and Sensors by Disease Type - Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Optogenetics Actuators and Sensors by Disease Type - Percentage Breakdown of Value Sales for Retinal Disorders, Parkinson's Disease, Autism, Anxiety & Depression, Schizophrenia and Other Disease Types for the Years 2014, 2024 & 2030

IV. COMPETITION